| John Denzil Babb, MD | |
|
185 Montague St, Fl 12, Brooklyn, NY 11201-3600 | |
| (718) 783-1616 | |
| (718) 783-8002 |
| Full Name | John Denzil Babb |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 44 Years |
| Location | 185 Montague St, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003819343 | NPI | - | NPPES |
| 00861096 | Medicaid | NY | |
| 1C5965 | Other | NY | PHS |
| 113000396 | Other | NY | EMPIREPLAN |
| 146595-A21 | Other | NY | HEALTHFIRST65 |
| 566025 | Other | NY | UNITED HEALTHCARE |
| 164587 | Other | NY | ELDERPLAN |
| 4270599 | Other | NY | AETNA |
| 566025 | Other | NY | UNITED HEALTH CARE |
| 113000396 | Other | NY | NATIONAL BENEFIT PLAN |
| 4270599 | Other | NY | AETNAUSHEALTH |
| KS0101 | Other | NY | OXFORD |
| 0021193 | Other | NY | GHI |
| 27342P | Other | NY | HIP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 1465951 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John D Babb Md Pc | 1557251972 | 3 |
News Archive
Today's announcement of renewed support for cancer control by Prime Minister Harper is great news for Canadians. The Canadian Partnership Against Cancer is receiving a second five-year mandate, to begin in 2012, and $250 million in funding to continue implementation of Canada's national cancer control strategy.
The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
Ms Hewitt has promised a "much stronger" legal framework in the National Health Service (NHS) to help hospitals reduce the rate of antibiotic-resistant MRSA and other hospital acquired infections.
Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.
› Verified 6 days ago
| Entity Name | John D Babb Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609963644 PECOS PAC ID: 1557251972 Enrollment ID: O20090709000593 |
News Archive
Today's announcement of renewed support for cancer control by Prime Minister Harper is great news for Canadians. The Canadian Partnership Against Cancer is receiving a second five-year mandate, to begin in 2012, and $250 million in funding to continue implementation of Canada's national cancer control strategy.
The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
Ms Hewitt has promised a "much stronger" legal framework in the National Health Service (NHS) to help hospitals reduce the rate of antibiotic-resistant MRSA and other hospital acquired infections.
Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Denzil Babb, MD 185 Montague St, Fl 12, Brooklyn, NY 11201-3600 Ph: (718) 783-1616 | John Denzil Babb, MD 185 Montague St, Fl 12, Brooklyn, NY 11201-3600 Ph: (718) 783-1616 |
News Archive
Today's announcement of renewed support for cancer control by Prime Minister Harper is great news for Canadians. The Canadian Partnership Against Cancer is receiving a second five-year mandate, to begin in 2012, and $250 million in funding to continue implementation of Canada's national cancer control strategy.
The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
Ms Hewitt has promised a "much stronger" legal framework in the National Health Service (NHS) to help hospitals reduce the rate of antibiotic-resistant MRSA and other hospital acquired infections.
Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.
› Verified 6 days ago
Dr. Allison Estes Rizzuti, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 451 Clarkson Avenue, E-building, 8th Floor, Suite C-8w47, Brooklyn, NY 11203 Phone: 718-245-2167 | |
Mrs. Ellen Pan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8301 Bay Parkway, Suite 103, Brooklyn, NY 11214 Phone: 718-236-7772 Fax: 718-256-4178 | |
Dr. Michael J. D'alto, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 20 Plaza St, Brooklyn, NY 11238 Phone: 718-636-1333 Fax: 718-833-5237 | |
Mark Harooni, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 109 4th Ave, Brooklyn, NY 11217 Phone: 718-438-5600 Fax: 917-386-2679 | |
Dr. Mitchell Steven Seidman, DO Ophthalmology Medicare: Medicare Enrolled Practice Location: 2989 Ocean Pkwy, Brooklyn, NY 11235 Phone: 718-332-2020 Fax: 718-332-3248 | |
Irina Pankova, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 445 Kings Hwy, 1st Floor, Brooklyn, NY 11223 Phone: 718-645-2201 Fax: 718-645-2207 |